SignalXSignalX

SNDX Syndax Pharmaceuticals Inc

8-K Current Report
Filed: February 26, 2026
Health Care
Pharmaceutical Preparations
Syndax Pharmaceuticals Inc Overview

Syndax Pharmaceuticals Inc (SNDX) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q1 2025 earnings press release referenced via exhibit — full financial results in accompanying exhibit, not inline text
  • • Boilerplate language confirms results disclosure is Reg FD-compliant but not incorporated by reference into SEC filings

Get deeper insights on Syndax Pharmaceuticals Inc

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.